ArticleJournal of cutaneous medicine and surgery

Certolizumab Pegol Use in the Treatment of Moderate-to-Severe Psoriasis: Real-World Data From Two Canadian Centers.

Ronald B Vender et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.